 Allison Blackmer
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parenteral Nutrition | 10 | 2024 | 108 | 2.180 |
Why?
| | Education, Pharmacy | 5 | 2018 | 135 | 1.800 |
Why?
| | Fat Emulsions, Intravenous | 4 | 2024 | 29 | 1.590 |
Why?
| | Faculty, Pharmacy | 4 | 2017 | 20 | 1.440 |
Why?
| | Schools, Pharmacy | 4 | 2017 | 54 | 1.410 |
Why?
| | Career Mobility | 4 | 2017 | 68 | 1.380 |
Why?
| | Pharmacists | 5 | 2017 | 262 | 1.270 |
Why?
| | Career Choice | 4 | 2017 | 211 | 1.230 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 151 | 1.070 |
Why?
| | Cholestasis | 3 | 2024 | 230 | 0.890 |
Why?
| | Malnutrition | 5 | 2023 | 78 | 0.760 |
Why?
| | Nervous System Diseases | 2 | 2021 | 251 | 0.750 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 757 | 0.730 |
Why?
| | Cannabidiol | 2 | 2022 | 90 | 0.730 |
Why?
| | Clostridium Infections | 1 | 2021 | 56 | 0.710 |
Why?
| | Motor Disorders | 1 | 2020 | 16 | 0.690 |
Why?
| | Muscle Spasticity | 1 | 2020 | 55 | 0.670 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2019 | 17 | 0.620 |
Why?
| | Cerebral Palsy | 1 | 2020 | 92 | 0.610 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 67 | 0.610 |
Why?
| | Disabled Persons | 1 | 2020 | 140 | 0.610 |
Why?
| | Parenteral Nutrition Solutions | 2 | 2015 | 3 | 0.590 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 120 | 0.560 |
Why?
| | Professional Competence | 1 | 2017 | 95 | 0.550 |
Why?
| | Teaching | 1 | 2018 | 209 | 0.530 |
Why?
| | Medication Adherence | 1 | 2021 | 573 | 0.520 |
Why?
| | Educational Measurement | 1 | 2018 | 261 | 0.520 |
Why?
| | Chronic Disease | 2 | 2021 | 1701 | 0.510 |
Why?
| | Enteral Nutrition | 5 | 2023 | 184 | 0.510 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 249 | 0.500 |
Why?
| | Selenium | 1 | 2015 | 36 | 0.470 |
Why?
| | Trace Elements | 1 | 2015 | 46 | 0.460 |
Why?
| | Empyema, Pleural | 1 | 2014 | 12 | 0.440 |
Why?
| | Pleural Effusion | 1 | 2014 | 48 | 0.430 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 68 | 0.420 |
Why?
| | Central Nervous System | 1 | 2014 | 255 | 0.400 |
Why?
| | Pediatrics | 4 | 2021 | 1061 | 0.390 |
Why?
| | Tissue Plasminogen Activator | 1 | 2014 | 220 | 0.390 |
Why?
| | Copper | 1 | 2012 | 108 | 0.380 |
Why?
| | Cross Infection | 1 | 2013 | 196 | 0.380 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 249 | 0.370 |
Why?
| | Laxatives | 1 | 2010 | 19 | 0.350 |
Why?
| | Dietary Fiber | 1 | 2010 | 50 | 0.350 |
Why?
| | Soybean Oil | 2 | 2024 | 14 | 0.340 |
Why?
| | Child | 12 | 2023 | 20721 | 0.330 |
Why?
| | Constipation | 1 | 2010 | 89 | 0.330 |
Why?
| | Humans | 35 | 2024 | 128524 | 0.320 |
Why?
| | Polysaccharides | 1 | 2009 | 81 | 0.320 |
Why?
| | Hospitalization | 2 | 2021 | 2071 | 0.320 |
Why?
| | Pneumonia | 1 | 2014 | 599 | 0.290 |
Why?
| | Thrombocytopenia | 1 | 2009 | 182 | 0.280 |
Why?
| | Infant | 7 | 2024 | 8913 | 0.270 |
Why?
| | Students, Pharmacy | 2 | 2018 | 112 | 0.270 |
Why?
| | Professional Role | 2 | 2017 | 160 | 0.260 |
Why?
| | Nutritional Support | 4 | 2022 | 31 | 0.260 |
Why?
| | Child, Preschool | 6 | 2021 | 10373 | 0.260 |
Why?
| | Anticoagulants | 1 | 2009 | 613 | 0.240 |
Why?
| | Nutrition Disorders | 1 | 2023 | 24 | 0.220 |
Why?
| | Food, Formulated | 1 | 2023 | 14 | 0.220 |
Why?
| | Infant, Newborn | 5 | 2024 | 5687 | 0.220 |
Why?
| | Bilirubin | 1 | 2024 | 92 | 0.220 |
Why?
| | Dietetics | 1 | 2023 | 22 | 0.210 |
Why?
| | Epilepsies, Myoclonic | 1 | 2022 | 45 | 0.190 |
Why?
| | Nutrition Therapy | 1 | 2022 | 31 | 0.190 |
Why?
| | Pharmaceutical Services | 1 | 2022 | 83 | 0.190 |
Why?
| | Public-Private Sector Partnerships | 1 | 2021 | 42 | 0.190 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 11 | 0.180 |
Why?
| | Vancomycin | 1 | 2021 | 71 | 0.180 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 59 | 0.170 |
Why?
| | United States | 9 | 2023 | 13876 | 0.170 |
Why?
| | Medication Therapy Management | 1 | 2020 | 72 | 0.170 |
Why?
| | Symptom Assessment | 1 | 2020 | 125 | 0.160 |
Why?
| | Analgesics | 1 | 2020 | 165 | 0.160 |
Why?
| | Health Personnel | 2 | 2023 | 646 | 0.150 |
Why?
| | Preceptorship | 1 | 2018 | 72 | 0.150 |
Why?
| | Employee Performance Appraisal | 1 | 2017 | 7 | 0.150 |
Why?
| | Faculty | 1 | 2018 | 135 | 0.140 |
Why?
| | Male | 8 | 2024 | 62883 | 0.140 |
Why?
| | Feedback | 1 | 2017 | 159 | 0.140 |
Why?
| | Female | 8 | 2024 | 68127 | 0.130 |
Why?
| | Medicare | 1 | 2022 | 718 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 1943 | 0.130 |
Why?
| | Adolescent | 3 | 2021 | 20213 | 0.120 |
Why?
| | Electrolytes | 1 | 2015 | 58 | 0.120 |
Why?
| | Nutritionists | 1 | 2014 | 16 | 0.120 |
Why?
| | Infant, Premature | 2 | 2024 | 536 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 153 | 0.110 |
Why?
| | Adult | 5 | 2023 | 35315 | 0.110 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 5346 | 0.110 |
Why?
| | Academies and Institutes | 1 | 2014 | 48 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 749 | 0.110 |
Why?
| | Vitamins | 1 | 2015 | 172 | 0.110 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 5040 | 0.110 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2015 | 137 | 0.110 |
Why?
| | Parents | 1 | 2020 | 1306 | 0.100 |
Why?
| | Curriculum | 1 | 2018 | 921 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 646 | 0.100 |
Why?
| | Clinical Competence | 1 | 2018 | 1014 | 0.090 |
Why?
| | Amino Acids | 1 | 2015 | 474 | 0.090 |
Why?
| | Infant, Premature, Diseases | 1 | 2012 | 95 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1667 | 0.090 |
Why?
| | Nutritional Status | 2 | 2023 | 326 | 0.090 |
Why?
| | Survival Analysis | 1 | 2013 | 1265 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1197 | 0.090 |
Why?
| | Young Adult | 2 | 2019 | 12320 | 0.080 |
Why?
| | Glucose | 1 | 2015 | 983 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2014 | 10163 | 0.080 |
Why?
| | Logistic Models | 1 | 2014 | 1975 | 0.080 |
Why?
| | Quality of Life | 1 | 2020 | 2680 | 0.080 |
Why?
| | Child Welfare | 1 | 2010 | 211 | 0.080 |
Why?
| | Heparin | 1 | 2009 | 240 | 0.070 |
Why?
| | Critical Illness | 1 | 2013 | 729 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2619 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2015 | 14460 | 0.070 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1490 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3256 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 998 | 0.060 |
Why?
| | Liver | 1 | 2012 | 1827 | 0.060 |
Why?
| | Societies | 1 | 2023 | 36 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 3117 | 0.050 |
Why?
| | Algorithms | 1 | 2010 | 1616 | 0.050 |
Why?
| | Fenfluramine | 1 | 2022 | 13 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2023 | 85 | 0.050 |
Why?
| | Prospective Studies | 1 | 2014 | 7043 | 0.050 |
Why?
| | Drug Storage | 1 | 2022 | 53 | 0.050 |
Why?
| | Drug Stability | 1 | 2022 | 144 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7040 | 0.050 |
Why?
| | Epileptic Syndromes | 1 | 2022 | 78 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2022 | 198 | 0.050 |
Why?
| | Spasms, Infantile | 1 | 2022 | 118 | 0.040 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 41 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2022 | 197 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 170 | 0.040 |
Why?
| | Aged | 2 | 2022 | 21971 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2021 | 171 | 0.040 |
Why?
| | Temperature | 1 | 2022 | 625 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 395 | 0.040 |
Why?
| | Research | 1 | 2021 | 409 | 0.040 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 147 | 0.040 |
Why?
| | Health Care Costs | 1 | 2021 | 395 | 0.040 |
Why?
| | Work | 1 | 2017 | 18 | 0.040 |
Why?
| | Time Management | 1 | 2017 | 20 | 0.040 |
Why?
| | Data Collection | 1 | 2020 | 649 | 0.040 |
Why?
| | Precision Medicine | 1 | 2021 | 383 | 0.030 |
Why?
| | Occupational Stress | 1 | 2017 | 39 | 0.030 |
Why?
| | Patient Care Team | 1 | 2022 | 600 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 631 | 0.030 |
Why?
| | Intestinal Diseases | 1 | 2016 | 35 | 0.030 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 213 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2016 | 104 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1121 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 180 | 0.030 |
Why?
| | Diet | 1 | 2023 | 1200 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 291 | 0.030 |
Why?
| | Patient Discharge | 1 | 2021 | 849 | 0.030 |
Why?
| | Pain | 1 | 2020 | 756 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2017 | 425 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 386 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2736 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 1100 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1271 | 0.020 |
Why?
| | Middle Aged | 1 | 2013 | 30893 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4392 | 0.020 |
Why?
|
|
Blackmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|